🇺🇸 FDA
Pipeline program

A Study of JNJ-90301900 in Combination with Concurrent Chemoradiation Therapy in LA HNSCC

90301900HNC1001

Phase 1 other active

Quick answer

A Study of JNJ-90301900 in Combination with Concurrent Chemoradiation Therapy in LA HNSCC for Locally Advanced Head and Neck Squamous Cell Carcinoma (LA HNSCC) is a Phase 1 program (other) at Janssen-Cilag International N.V. with 1 ClinicalTrials.gov record(s).

Program details

Company
Janssen-Cilag International N.V.
Indication
Locally Advanced Head and Neck Squamous Cell Carcinoma (LA HNSCC)
Phase
Phase 1
Modality
other
Status
active

Clinical trials